1. Delgado KZ, Navarrete RR. Epidermolysis Bullosa: Innovative Treatment with Stem Cells, a Systematic Review. 2024.doi: 10.56294/saludcyt20241193 [DOI:10.56294/saludcyt20241193]

2. Has C, Liu L, Bolling M, Charlesworth A, El Hachem M, Escámez M, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. The British journal of dermatology. 2019;182(3):574.doi: 10.1111/bjd.18128 [DOI:10.1111/bjd.18128] [PMID] []

3. Bischof J, Hierl M, Koller U. Emerging gene therapeutics for epidermolysis bullosa under development. International journal of molecular sciences. 2024;25(4):2243.doi: 10.3390/ijms25042243 [DOI:10.3390/ijms25042243] [PMID] []

4. Lucky AW, Whalen J, Rowe S, Marathe KS, Gorell E. Diagnosis and care of the newborn with epidermolysis bullosa. Neoreviews. 2021;22(7):e438-e51.doi: 10.3390/ijms25042243 [DOI:10.3390/ijms25042243] [PMID] []

5. So JY, Teng J. Epidermolysis bullosa simplex. 2022. PMID: 20301543

6. Kueckelhaus M, Rothoeft T, De Rosa L, Yeni B, Ohmann T, Maier C, et al. Transgenic epidermal cultures for junctional epidermolysis bullosa-5-year outcomes. New England Journal of Medicine. 2021;385(24):2264-70.doi: 10.1056/NEJMoa2108544 [DOI:10.1056/NEJMoa2108544] [PMID]

7. Uitto J, Bruckner-Tuderman L, McGrath JA, Riedl R, Robinson C. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure. Journal of Investigative Dermatology. 2018;138(5):1010-6.doi: 10.1016/j.jid.2017.12.016 [DOI:10.1016/j.jid.2017.12.016] [PMID]

8. Marinkovich MP, Tang JY. Gene Therapy for Epidermolysis Bullosa. Journal of Investigative Dermatology. 2019;139(6):1221-6. [DOI:10.1016/j.jid.2018.11.036] [PMID]

9. Salera S, Tadini G, Rossetti D, Grassi FS, Marchisio P, Agostoni C, et al. A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management. Clinical Nutrition. 2020;39(2):343-52.doi: 10.1016/j.clnu.2019.02.023 [DOI:10.1016/j.clnu.2019.02.023] [PMID]

10. Natsuga K, Shinkuma S, Hsu C-K, Fujita Y, Ishiko A, Tamai K, et al. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges. Journal of Dermatological Science. 2021;104(3):164-76.doi: 10.1016/j.jdermsci.2021.11.004 [DOI:10.1016/j.jdermsci.2021.11.004] [PMID]

11. Morgan G, Back E, Rosa D, Irwin J, Ferguson S, Carr E. PCR240 A Cross-Sectional Study of Disease Severity and Health Related Quality of Life in Epidermolysis Bullosa. Value in Health. 2022;25(12, Supplement):S436. [DOI:10.1016/j.jval.2022.09.2173]

12. Mellerio JE, Kiritsi D, Marinkovich MP, Haro NR, Badger K, Arora M, et al. Mapping the burden of severe forms of epidermolysis bullosa - Implications for patient management. JAAD International. 2023;11:224-32.doi: 10.1016/j.jdin.2023.02.016 [DOI:10.1016/j.jdin.2023.02.016] [PMID] []

13. Park M, Sachdeva M, Mistry J, Abou Ali Waked J, Abduelmula A, Maliyar K, et al. Clinical manifestations and treatment outcomes in epidermolysis bullosa pruriginosa: A systematic review. JAAD Reviews. 2024;1:1-3. [DOI:10.1016/j.jdrv.2024.05.003]

14. Bruckner AL, Losow M, Wisk J, Patel N, Reha A, Lagast H, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet journal of rare diseases. 2020;15:1-14.doi: 10.1186/s13023-019-1279-y [DOI:10.1186/s13023-019-1279-y] [PMID] []

15. Petrof G, Papanikolaou M, Martinez AE, Mellerio JE, McGrath JA, Bardhan A, et al. The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database. British Journal of Dermatology. 2022;186(5):843-8.doi: 10.1111/bjd.20958 [DOI:10.1111/bjd.20958] [PMID]

16. Hou P-C, Wang H-T, Abhee S, Tu W-T, McGrath JA, Hsu C-K. Investigational treatments for epidermolysis bullosa. American Journal of Clinical Dermatology. 2021;22:801-17.doi: 10.1007/s40257-021-00626-3 [DOI:10.1007/s40257-021-00626-3] [PMID]

17. Marchili MR, Spina G, Roversi M, Mascolo C, Pentimalli E, Corbeddu M, et al. Epidermolysis Bullosa in children: the central role of the pediatrician. Orphanet journal of rare diseases. 2022;17(1):147.doi: 10.1186/s13023-021-02144-1 [DOI:10.1186/s13023-021-02144-1] [PMID] []

18. Hon KL, Chu S, Leung AK. Epidermolysis bullosa: pediatric perspectives. Current pediatric reviews. 2022;18(3):182-90.doi: 10.2174/1573396317666210525161252 [DOI:10.2174/1573396317666210525161252] [PMID]

19. Prodinger C, Reichelt J, Bauer JW, Laimer M. Epidermolysis bullosa: Advances in research and treatment. Experimental dermatology. 2019;28(10):1176-89.doi: 10.1111/exd.13979 [DOI:10.1111/exd.13979] [PMID] []

20. Bruckner-Tuderman L. Newer treatment modalities in epidermolysis bullosa. Indian Dermatology Online Journal. 2019;10(3):244-50.doi: 10.4103/idoj.IDOJ_287_18 [DOI:10.4103/idoj.IDOJ_287_18] [PMID] []

21. Has C, South A, Uitto J. Molecular therapeutics in development for epidermolysis bullosa: update 2020. Molecular Diagnosis & Therapy. 2020;24(3):299-309.doi: 10.1007/s40291-020-00466-7 [DOI:10.1007/s40291-020-00466-7] [PMID] []

22. Tešanović Perković D, Bukvić Mokos Z, Marinović B. Epidermolysis bullosa Acquisita-current and emerging treatments. Journal of clinical medicine. 2023;12(3):1139. [DOI:10.3390/jcm12031139] [PMID] []

23. Delgado KZ, Navarrete RR. Epidermolysis Bullosa: Innovative Treatment with Stem Cells, a Systematic Review. 2024.doi: 10.56294/saludcyt20241193 [DOI:10.56294/saludcyt20241193]

24. Has C, Liu L, Bolling M, Charlesworth A, El Hachem M, Escámez M, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. The British journal of dermatology. 2019;182(3):574.doi: 10.1111/bjd.18128 [DOI:10.1111/bjd.18128] [PMID] []

25. Bischof J, Hierl M, Koller U. Emerging gene therapeutics for epidermolysis bullosa under development. International journal of molecular sciences. 2024;25(4):2243.doi: 10.3390/ijms25042243 [DOI:10.3390/ijms25042243] [PMID] []

26. Lucky AW, Whalen J, Rowe S, Marathe KS, Gorell E. Diagnosis and care of the newborn with epidermolysis bullosa. Neoreviews. 2021;22(7):e438-e51.doi: 10.3390/ijms25042243 [DOI:10.3390/ijms25042243] [PMID] []

27. So JY, Teng J. Epidermolysis bullosa simplex. 2022. PMID: 20301543

28. Kueckelhaus M, Rothoeft T, De Rosa L, Yeni B, Ohmann T, Maier C, et al. Transgenic epidermal cultures for junctional epidermolysis bullosa-5-year outcomes. New England Journal of Medicine. 2021;385(24):2264-70.doi: 10.1056/NEJMoa2108544 [DOI:10.1056/NEJMoa2108544] [PMID]

29. Uitto J, Bruckner-Tuderman L, McGrath JA, Riedl R, Robinson C. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure. Journal of Investigative Dermatology. 2018;138(5):1010-6.doi: 10.1016/j.jid.2017.12.016 [DOI:10.1016/j.jid.2017.12.016] [PMID]

30. Marinkovich MP, Tang JY. Gene Therapy for Epidermolysis Bullosa. Journal of Investigative Dermatology. 2019;139(6):1221-6. [DOI:10.1016/j.jid.2018.11.036] [PMID]

31. Salera S, Tadini G, Rossetti D, Grassi FS, Marchisio P, Agostoni C, et al. A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management. Clinical Nutrition. 2020;39(2):343-52.doi: 10.1016/j.clnu.2019.02.023 [DOI:10.1016/j.clnu.2019.02.023] [PMID]

32. Natsuga K, Shinkuma S, Hsu C-K, Fujita Y, Ishiko A, Tamai K, et al. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges. Journal of Dermatological Science. 2021;104(3):164-76.doi: 10.1016/j.jdermsci.2021.11.004 [DOI:10.1016/j.jdermsci.2021.11.004] [PMID]

33. Morgan G, Back E, Rosa D, Irwin J, Ferguson S, Carr E. PCR240 A Cross-Sectional Study of Disease Severity and Health Related Quality of Life in Epidermolysis Bullosa. Value in Health. 2022;25(12, Supplement):S436. [DOI:10.1016/j.jval.2022.09.2173]

34. Mellerio JE, Kiritsi D, Marinkovich MP, Haro NR, Badger K, Arora M, et al. Mapping the burden of severe forms of epidermolysis bullosa - Implications for patient management. JAAD International. 2023;11:224-32.doi: 10.1016/j.jdin.2023.02.016 [DOI:10.1016/j.jdin.2023.02.016] [PMID] []

35. Park M, Sachdeva M, Mistry J, Abou Ali Waked J, Abduelmula A, Maliyar K, et al. Clinical manifestations and treatment outcomes in epidermolysis bullosa pruriginosa: A systematic review. JAAD Reviews. 2024;1:1-3. [DOI:10.1016/j.jdrv.2024.05.003]

36. Bruckner AL, Losow M, Wisk J, Patel N, Reha A, Lagast H, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet journal of rare diseases. 2020;15:1-14.doi: 10.1186/s13023-019-1279-y [DOI:10.1186/s13023-019-1279-y] [PMID] []

37. Petrof G, Papanikolaou M, Martinez AE, Mellerio JE, McGrath JA, Bardhan A, et al. The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database. British Journal of Dermatology. 2022;186(5):843-8.doi: 10.1111/bjd.20958 [DOI:10.1111/bjd.20958] [PMID]

38. Hou P-C, Wang H-T, Abhee S, Tu W-T, McGrath JA, Hsu C-K. Investigational treatments for epidermolysis bullosa. American Journal of Clinical Dermatology. 2021;22:801-17.doi: 10.1007/s40257-021-00626-3 [DOI:10.1007/s40257-021-00626-3] [PMID]

39. Marchili MR, Spina G, Roversi M, Mascolo C, Pentimalli E, Corbeddu M, et al. Epidermolysis Bullosa in children: the central role of the pediatrician. Orphanet journal of rare diseases. 2022;17(1):147.doi: 10.1186/s13023-021-02144-1 [DOI:10.1186/s13023-021-02144-1] [PMID] []

40. Hon KL, Chu S, Leung AK. Epidermolysis bullosa: pediatric perspectives. Current pediatric reviews. 2022;18(3):182-90.doi: 10.2174/1573396317666210525161252 [DOI:10.2174/1573396317666210525161252] [PMID]

41. Prodinger C, Reichelt J, Bauer JW, Laimer M. Epidermolysis bullosa: Advances in research and treatment. Experimental dermatology. 2019;28(10):1176-89.doi: 10.1111/exd.13979 [DOI:10.1111/exd.13979] [PMID] []

42. Bruckner-Tuderman L. Newer treatment modalities in epidermolysis bullosa. Indian Dermatology Online Journal. 2019;10(3):244-50.doi: 10.4103/idoj.IDOJ_287_18 [DOI:10.4103/idoj.IDOJ_287_18] [PMID] []

43. Has C, South A, Uitto J. Molecular therapeutics in development for epidermolysis bullosa: update 2020. Molecular Diagnosis & Therapy. 2020;24(3):299-309.doi: 10.1007/s40291-020-00466-7 [DOI:10.1007/s40291-020-00466-7] [PMID] []

44. Tešanović Perković D, Bukvić Mokos Z, Marinović B. Epidermolysis bullosa Acquisita-current and emerging treatments. Journal of clinical medicine. 2023;12(3):1139. [DOI:10.3390/jcm12031139] [PMID] []